Nuclear morphometry and glutathione S-transferase π expression in breast cancer

Oncology Reports

Volumn 7, Issue 3, 2000, Pages 609-613

  Huang, Jingxiang ^a   Bay, Boon Huat ^a   Tan, Puay Hoon ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Breast cancer; GST expression; Image analysis; Immunohistochemistry

Indexed keywords

ESTROGEN RECEPTOR; GLUTATHIONE TRANSFERASE; ISOENZYME; PROGESTERONE RECEPTOR;

ARTICLE; BREAST; BREAST TUMOR; CANCER INVASION; CELL NUCLEUS; ENZYMOLOGY; FEMALE; HUMAN; LYMPH NODE METASTASIS; PATHOLOGY;

BREAST; BREAST NEOPLASMS; CELL NUCLEUS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0034183159     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Baak JPA, Chin D, van Diest PJ, Ortiz R, Matze-Cok P and Bacus SS: Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Lab Invest 164: 215-223, 1991.
2. MacGrogan G, Bonichon F, de Mascarel I, Trojani M, Durand M, Avril A and Coindre JM: Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases. Breast Cancer Res Treat 36: 83-91, 1995.
3. Ioakim-Liossi A, Karakitsos P, Markopoulos CH, Aroni K, Grogas J and Kyrkou K: DNA ploidy and vimentin expression in primary breast cancer. Cytopathol 6: 325-330, 1995.
4. Howie AF, Forrester LM, Glancy MJ, et al: Glutathione-S-transferase and glutathione peroxidase expression in normal and tumor human tissues. Carcinogenesis 11: 451-458, 1990.
5. Forrester LM, Wolf CR, Powis G, Schlager JJ, Harris AL and Barnes D: Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis 11: 2163-2170, 1990.
6. Singh SV, Brunnert SR, Roberts B and Krishnan A: Differential expression of glutathione S-transferase, glutathione peroxidase and glutathione reductase in normal and malignant human breast tissues. Cancer Lett 51: 43-48, 1990.
7. Hayes JD and Pulford DJ: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995.
8. Kelley MK, Kauvar LM, Schmidt DE, Wheatley JB, Montali JA and Engqvist-Goldstein A: Variability of glutathione S-transferase isoenzyme patterns in matched normal and cancer human breast tissue. Biochem J 304: 843-848, 1994.
9. Howie AF, Miller WR, Hawkins RA, Hutchinson AR and Beckett GJ: Expression of glutathione S-transferase B1, B2, mu and pi in breast cancers and their relationship to oestrogen receptor status. Br J Cancer 60: 834-837, 1989.
10. Sato K: Glutathione transferases as markers of preneoplasia. Adv Cancer Res 52: 205-255, 1989.
11. Baptist G, Tulpule A, Sinha BK, Katki AG, Myers CE and Cowan KH: Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261: 15544-15549, 1986.
12. Peters WHM, Roelofs HMJ, van Putten WLJ, Jansen JBMJ, Klijn JGM and Foekens JA: Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br J Cancer 68: 86-92, 1993.
13. MacGrogan G, Mauriac L, Durand M, et al: Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GSTπ. Br J Cancer 74: 1458-1465, 1996.
14. Chen G and Waxman DJ: Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells. Biochem Pharmacol 49: 1691-1701, 1995.
15. Gilbert L, Elwood LJ, Merino M, et al: A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with oestrogen receptor expression and prognosis in node negative breast cancer. J Clin Oncol 11: 49-58, 1993.
16. Slater AFG, Nobel CSI and Orrenius S: The role of intracellular oxidants in apoptosis. Biochim Biophys Acta 1271: 59-62, 1995.
17. Terrier P, Cowan KH, Triche TJ, Coindre JM and Townsend AJ: An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol 137: 845-853, 1990.
18. Pienta KJ and Coffey DS: Correlation of nuclear morphometry with progression of breast cancer. Cancer 68: 2012-2016, 1991.
19. Murray GI, Weaver RJ, Paterson PJ, Ewen SWB, Melvin WT and Burke MD: Expression of xenobiotic metabolizing enzymes in breast cancer. J Pathol 169: 347-353, 1993.
20. Silvestrini R, Veronesi U, Zucali R, Kenda R, Maucione A and Leutner M: Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Natl Cancer Inst 89: 605-607, 1997.
21. Bellamy COC and Harrison DJ: Evaluation of glutathione S-transferase pi in non-invasive ductal carcinoma of breast. Br J Cancer 69: 183-185, 1994.
22. Albin N, Massaad L, Toussaint C, et al: Main drug metabolising enzyme systems in human breast tumors and peritumoral tissues. Cancer Res 53: 3541-3546, 1993.
23. Frierson HF Jr, Williams ME, Boyd JC, Meredith SD and Gaffey MJ: Immunohistochemical staining and Southern blot hybridisation for glutathione S-transferase pi in mammary infiltrating ductal carcinoma. Mod Pathol 8: 643-647, 1995.
24. Molina R, Oesterrich S, Zhou JL, et al: Glutathione transferase GST pi in breast tumors evaluated by three techniques. Dis Markers 11: 71-82, 1993.
25. Aaltomaa S, Lipponen P, Klemi P, et al: Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer. Eur J Surg 158: 135-141, 1992.
26. Lythgoe JP, Leck I and Swindell R: Manchester regional breast study: preliminary results. Lancet i: 744-777, 1978.
27. Nemoto K, Vana J, Bedwani RN, Baker HW, McGregor FH and Murphy GP: Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45: 2917-2924, 1980.
28. Baak JP, Kurver PHJ, De-Snoo Niewlaat AJE, De Graaf S, Makkink B and Boon ME: Prognostic indicators in breast cancer - morphometric methods. Histopathology 6: 327-339, 1982.
29. Slater AFG, Stefan C, Nobel I, van den Dobbelsteen DJ and Orrenius S: Intracellular redox changes during apoptosis. Cell Death Differ 3: 57-62, 1996.
30. Briehl MM and Baker AF: Modulation of the antioxidant defence as a factor in apoptosis. Cell Death Differ 3: 63-70, 1996.
31. Bauer G: Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. Histopathology 11: 237-255, 1996.
32. Haroske G, Dimmer V, Friedrich K, et al: Nuclear image analysis of immunohistochemically stained cells in breast carcinomas. Histochem Cell Biol 105: 479-485, 1996.